Literature DB >> 33333151

PERFORMANCE OF SALAMANCA'S REFINEMENT OF THE T3-AJCC8 VERSUS THE BRIGHAM AND WOMEN'S HOSPITAL AND TÜBINGEN ALTERNATIVE STAGING SYSTEMS FOR HIGH-RISK CUTANEOUS SQUAMOUS CELL CARCINOMA.

Laura Puebla-Tornero1, Luis Antonio Corchete-Sánchez2, Alberto Conde-Ferreirós1, Natalia García-Sancha3, Roberto Corchado-Cobos3, Concepción Román-Curto4, Javier Cañueto5.   

Abstract

INTRODUCTION: The Brigham and Women's Hospital (BWH) and the Tübingen cutaneous squamous cell carcinoma (CSCC) stratification systems propose different criteria from the AJCC8. Our group identified prognostic subgroups within T3-AJCC8, the most common classification for high-risk CSCCs (HR-CSCCs).
OBJECTIVE: To compare the performance and prognostic accuracy of these staging systems in a subset of HR-CSCCs.
METHODS: Homogeneity, monotonicity and McNemar tests for pair-wise comparisons were assessed. Distinctiveness and relative risk of poor outcome were calculated by stage. Prognostic accuracy was compared with respect to quality (AIC and BIC), concordance (Harrell C-index, Gönen & Heller CPE) and predictive accuracy (sensitivity, specificity, negative predictive value [NPV], positive predictive value [PPV], global accuracy).
RESULTS: The BWH and Salamanca systems were more distinctive, homogeneous and monotonic than the Tübingen system. The Tübingen system was the most specific, while the Salamanca and BWH systems were more sensitive. NPV was high in all three systems, but PPV and accuracy were low overall.
CONCLUSIONS: Alternative staging systems may partially overcome the heterogeneity and low prognostic accuracy of the AJCC8 and enable HR-CSCCs to be stratified more reliably, but their prognostic accuracy is still low. Considering the accumulation of risk factors may improve HR-CSCC risk stratification.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  AJCC8; cutaneous squamous cell carcinoma; prognosis; skin cancer; staging

Year:  2020        PMID: 33333151     DOI: 10.1016/j.jaad.2020.12.020

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.

Authors:  Aaron S Farberg; Alison L Fitzgerald; Sherrif F Ibrahim; Stan N Tolkachjov; Teo Soleymani; Leah M Douglas; Sarah J Kurley; Sarah T Arron
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-07

2.  Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.

Authors:  Zoe Claire Venables; Selin Tokez; Loes M Hollestein; Antien L Mooyaart; Renate Ruth van den Bos; Brian Rous; Irene M Leigh; Tamar Nijsten; Marlies Wakkee
Journal:  Br J Dermatol       Date:  2022-03-26       Impact factor: 11.113

3.  Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.

Authors:  Jeremiah H Au; Perry B Hooper; Alison L Fitzgerald; Ally-Khan Somani
Journal:  Dermatol Ther (Heidelb)       Date:  2021-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.